Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19

MLA

Carsten Müller-Tidow, et al. “Lack of Antibodies against Seasonal Coronavirus OC43 Nucleocapsid Protein Identifies Patients at Risk of Critical COVID-19.” Journal of Clinical Virology, vol. 139, June 2021, p. 104847. EBSCOhost, https://doi.org/10.1016/j.jcv.2021.104847.

APA

Carsten Müller-Tidow, Marcel Vetter, Syrine Ellouze, Michaela Fontenay, Eva Lorentzen, Tanja Grote-Westrick, Martin Dugas, Frank Hanses, Uta Merle, Joachim Kuhn, Jérôme Duchemin, Richard Vollenberg, Phil-Robin Tepasse, Julia Fürst, Andreas E. Kremer, Philipp Schuster, Hartmut Schmidt, Shilpa Tiwari-Heckler, Tobias Brix, & Claudia M. Denkinger. (2021). Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19. Journal of Clinical Virology, 139, 104847. https://doi.org/10.1016/j.jcv.2021.104847

Chicago

Carsten Müller-Tidow, Marcel Vetter, Syrine Ellouze, Michaela Fontenay, Eva Lorentzen, Tanja Grote-Westrick, Martin Dugas, et al. 2021. “Lack of Antibodies against Seasonal Coronavirus OC43 Nucleocapsid Protein Identifies Patients at Risk of Critical COVID-19.” Journal of Clinical Virology 139 (June): 104847. doi:10.1016/j.jcv.2021.104847.